Akeso, Inc. (9926.HK)

HKD 87.8

(1.8%)

Total Liabilities Summary of Akeso, Inc.

  • Akeso, Inc.'s latest annual total liabilities in 2023 was 4.66 Billion CNY , up 58.16% from previous year.
  • Akeso, Inc.'s latest quarterly total liabilities in 2024 Q2 was 5.31 Billion CNY , down 0.0% from previous quarter.
  • Akeso, Inc. reported annual total liabilities of 2.94 Billion CNY in 2022, up 93.24% from previous year.
  • Akeso, Inc. reported annual total liabilities of 1.52 Billion CNY in 2021, up 275.99% from previous year.
  • Akeso, Inc. reported quarterly total liabilities of 4.66 Billion CNY for 2023 FY, up 58.16% from previous quarter.
  • Akeso, Inc. reported quarterly total liabilities of 4.09 Billion CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Akeso, Inc. (2023 - 2018)

Historical Annual Total Liabilities of Akeso, Inc. (2023 - 2018)

Year Total Liabilities Total Liabilities Growth
2023 4.66 Billion CNY 58.16%
2022 2.94 Billion CNY 93.24%
2021 1.52 Billion CNY 275.99%
2020 405.73 Million CNY -72.16%
2019 1.45 Billion CNY 790.6%
2018 163.62 Million CNY 0.0%

Peer Total Liabilities Comparison of Akeso, Inc.

Name Total Liabilities Total Liabilities Difference
Uni-Bio Science Group Limited 152.81 Million HKD -2950.893%
CK Life Sciences Int'l., (Holdings) Inc. 7.05 Billion HKD 33.944%